Nano-X Imaging Ltd. (NNOX)
| Market Cap | 25.07M -87.4% |
| Revenue (ttm) | 15.63M +31.5% |
| Net Income | -116.81M |
| EPS | -1.72 |
| Shares Out | 78.75M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,715,501 |
| Open | 0.3711 |
| Previous Close | 0.3639 |
| Day's Range | 0.3101 - 0.3756 |
| 52-Week Range | 0.2073 - 4.7050 |
| Beta | 1.36 |
| Analysts | Buy |
| Price Target | 4.13 (+1,198.05%) |
| Est. Earnings | Nov 23, 2026 |
About NNOX
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company’s solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to ... [Read more]
Financial Performance
In 2025, Nano-X Imaging's revenue was $13.02 million, an increase of 15.40% compared to the previous year's $11.28 million. Losses were -$75.02 million, 40.2% more than in 2024.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for NNOX stock is "Buy." The 12-month stock price target is $4.13, which is an increase of 1,198.05% from the latest price.
News
Nano-X Imaging board approves cost reduction measures
The company states: “Nano-X Imaging (NNOX) announced that the Board of Directors of the Company has approved a plan to reduce costs and improve operational efficiency. The plan approved by…
Nanox.AI Advances Commercial Collaboration with Dosy Health to Bring AI Cardiac Solution to Thailand
Collaboration builds on Dosy Health's established relationships with Mahidol University, Thammasat University and hospitals within the BDMS network, supporting planned distribution and commercializat...
Nanox Announces That Board Has Approved Cost Reduction and Operational Efficiency Measures
The Board approved plan target s a 25%–30% reduction in annualized operating expenses, compared to annualized 2026 GAAP and non-GAAP operating expenses, once fully implemented, expected by the end of ...
USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows
PETACH TIKVA, Israel, Nov. 9, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (“Nanox” or the “Company”, NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced that its wholly o...
TCT 2026 Clinical Data Reveals 84% Reporting Gap in Aortic Valve Calcification, Highlighting the Potential of Nanox.AI's AVC Solution
PETACH TIKVA, Israel , Nov . 2 , 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (“Nanox” or the “Company”, NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced that updated c...
Nano-X Imaging sees continued significant costs related to ongoing operations
On a preliminary unaudited basis, the company expects its cash, cash equivalents, short-term deposits and long-term restricted deposits to be approximately $26.0 million as of September 30, 2026, as c...
Nano-X Imaging sees Q3 revenue $4.3M-$4.4M vs. $3.4M last year
On a preliminary unaudited basis, the company expects its revenue to be approximately $4.3 to $4.4 million for the three months ended September 30, compared to $3.4 million for the…
Nano-X Imaging enters distribution agreement with Technologic
Nanox AI entered into a distribution agreement with Technologic s.r.l., an affiliate of Tecnologie Avanzate, to commercialize Nanox.AI’s Bone Solution in Italy. The collaboration leverages Tecnologie ...
Nanox Provides Business Update and Furnishes Certain Preliminary Unaudited Financial Data for Third Quarter Ended September 30, 2026
PETACH TIKVA, Israel, Oct. 16, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today provided a brief business ...
Nanox AI Ltd. Enters into Distribution Agreement with Technologic s.r.l.
Agreement aims to expand the commercial reach of Nanox.AI's Bone Solution in the Italian healthcare market. Collaboration leverages Tecnologie Avanzate's 50 years of experience in the Italian medical ...
Nanox Selected as One of TIME's Best Inventions of 2026 for its Nanox.ARC X
Nanox.ARC X recognized among the “world's most groundbreaking innovations” and for its approach to making advanced medical imaging more accessible
Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica
Agreement with SOLME RC, SA Marks the third Latin American market this year PETACH TIKVA, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd.
Nano-X Imaging reports Q2 EPS (79c), consensus (12c)
Reports Q2 revenue $4.16M, consensus $5.39M. “To date there has been tangible progress in our commercialization strategy. We have expanded our U.S. distribution footprint to ten partners and begun pat...
Nano-X Imaging Earnings Call Transcript: Q2 2026
Revenue grew 37% year-over-year to $4.2 million, driven by Health IT and teleradiology growth, but a $40.7 million impairment led to a GAAP net loss of $55.5 million. Commercialization advanced with new installations, partnerships, and a CMS reimbursement code for AI solutions.
Nano-X Imaging Earnings release: Q2 2026
Nano-X Imaging released its Q2 2026 earnings on September 9, 2026, summarizing the period's financial results.
Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates
PETACH TIKVA, Israel, Sept. 09, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the...
Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England
Expands Nanox's growing U.S. distribution network with a leading New England-based medical imaging provider PETACH TIKVA, Israel — September 4 2026 — Nano-X Imaging Ltd. (“Nanox”, or the “Company”, NA...
Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026
PETACH TIKVA, Israel, Aug. 25, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will repo...
Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom
Initial three-year term includes minimum annual license commitments PETACH TIKVA, ISRAEL, August 18 2026 -- Nanox Imaging Ltd. (“ Nanox”, or the “Company” NASDAQ: NNOX), a leader in innovative medical...
Urgent Deadline for Shareholders who lost money in shares of Nano-X Imaging Ltd. (NASDAQ: NNOX)
Today, August 11, 2026, is the Lead Plaintiff Deadline NEW YORK, Aug. 11, 2026 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldesnstein"), a nationally recognized securities litig...
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2026 in Nano-X Imaging Ltd. Lawsuit - NNOX
Important Information Regarding Section 20(a) Individual Liability Claims Against Nano-X Imaging's CEO and CFO for Alleged $33.4 Million Q4 Net Loss NEW YORK, Aug. 6, 2026 /PRNewswire/ -- SueWallSt al...
Nano-X Imaging Ltd. Announces Pricing of a $8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
PETACH TIKVA, Israel, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nano-X Imaging Ltd. (Nasdaq: NNOX), (“Nano-X” or the “Company”) an innovative medical imaging technology company, today announced that it has en...
Nano-X Imaging Ltd. Stockholders Who Suffered Significant Losses Should Contact Robbins LLP Before the August 11 Lead Plaintiff Deadline for Information About Their Rights Against NNOX
SAN DIEGO, Aug. 5, 2026 /PRNewswire/ -- Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities who purchased or otherwise acquired Nano-X Ima...
Shareholders Sue Nano-X Over Chip Fabrication and Customer Demand Claims
A class action lawsuit was filed against medical imaging company Nano-X Imaging ($NNOX) on June 12, 2026. The federal securities lawsuit alleges that plaintiffs acquired Nano-X stock at artificially i...
NNOX Investors Have Rights – If You Lost Money Investing in Nano-X Imaging Ltd. Contact Robbins LLP for Information About Recovering Your Losses
SAN DIEGO, July 09, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Nano-X Imaging Ltd. (NASDAQ: ...